223 related articles for article (PubMed ID: 32079998)
1. Contribution of COMT and BDNF Genotype and Expression to the Risk of Transition From Acute to Chronic Low Back Pain.
Baumbauer KM; Ramesh D; Perry M; Carney KB; Julian T; Glidden N; Dorsey SG; Starkweather AR; Young EE
Clin J Pain; 2020 Jun; 36(6):430-439. PubMed ID: 32079998
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain Susceptibility and Chronicity.
Ramesh D; D'Agata A; Starkweather AR; Young EE
Clin J Pain; 2018 Jan; 34(1):8-14. PubMed ID: 28481838
[TBL] [Abstract][Full Text] [Related]
3. A Role for Global DNA Methylation Level and
Eller OC; Glidden N; Knight B; McKearney N; Perry M; Bernier Carney KM; Starkweather A; Young EE; Baumbauer KM
Front Pain Res (Lausanne); 2021; 2():744148. PubMed ID: 35295525
[No Abstract] [Full Text] [Related]
4. Genetic contribution of catechol-O-methyltransferase variants in treatment outcome of low back pain: a prospective genetic association study.
Omair A; Lie BA; Reikeras O; Holden M; Brox JI
BMC Musculoskelet Disord; 2012 May; 13():76. PubMed ID: 22612913
[TBL] [Abstract][Full Text] [Related]
5. COMT and SCN9A gene variants do not contribute to chronic low back pain in Mexican-Mestizo patients.
Nava-Bringas TI; Manrique CMJ; González-Huerta NC; Morales-Hernández E; Miranda-Duarte A
Acta Neurochir (Wien); 2024 Feb; 166(1):73. PubMed ID: 38329587
[TBL] [Abstract][Full Text] [Related]
6. Human assumed central sensitization in people with acute non-specific low back pain: A cross-sectional study of the association with brain-derived neurotrophic factor, clinical, psychological and demographic factors.
Chang WJ; Jenkins LC; Humburg P; Schabrun SM
Eur J Pain; 2023 Apr; 27(4):530-545. PubMed ID: 36585941
[TBL] [Abstract][Full Text] [Related]
7. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
8. The COMT rs4680 Met allele contributes to long-lasting low back pain, sciatica and disability after lumbar disc herniation.
Jacobsen LM; Schistad EI; Storesund A; Pedersen LM; Rygh LJ; Røe C; Gjerstad J
Eur J Pain; 2012 Aug; 16(7):1064-9. PubMed ID: 22337560
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of Nav1.6 sodium channel, Brain-derived Neurotrophic Factor, Catechol-O-methyltransferase and Guanosine Triphosphate Cyclohydrolase 1 genes in trigeminal neuralgia.
Romero J; Costa GMF; Rocha LPC; Siqueira S; Moreira PR; Almeida-Leite CM
Clin Neurol Neurosurg; 2021 Sep; 208():106880. PubMed ID: 34418703
[TBL] [Abstract][Full Text] [Related]
10. COMT genotype and non-recovery after a whiplash injury in a Northern European population.
Rydman E; Comasco E; Pettersson H; Oreland L; Ponzer S; Ottosson C
BMC Musculoskelet Disord; 2017 Dec; 18(1):507. PubMed ID: 29195501
[TBL] [Abstract][Full Text] [Related]
11. Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.
Lin CH; Chaudhuri KR; Fan JY; Ko CI; Rizos A; Chang CW; Lin HI; Wu YR
Sci Rep; 2017 Jul; 7(1):6306. PubMed ID: 28740224
[TBL] [Abstract][Full Text] [Related]
12. Differences in Pain Processing Between Patients with Chronic Low Back Pain, Recurrent Low Back Pain, and Fibromyalgia.
Goubert D; Danneels L; Graven-Nielsen T; Descheemaeker F; Meeus M
Pain Physician; 2017 May; 20(4):307-318. PubMed ID: 28535553
[TBL] [Abstract][Full Text] [Related]
13. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase (COMT) gene polymorphisms are associated with baseline disability but not long-term treatment outcome in patients with chronic low back pain.
Omair A; Mannion AF; Holden M; Fairbank J; Lie BA; Hägg O; Fritzell P; Brox JI
Eur Spine J; 2015 Nov; 24(11):2425-31. PubMed ID: 25772090
[TBL] [Abstract][Full Text] [Related]
15. Cognitive ability, intraindividual variability, and common genetic variants of catechol-O-methyltransferase and brain-derived neurotrophic factor: a longitudinal study in a population-based sample of older adults.
Das D; Tan X; Bielak AA; Cherbuin N; Easteal S; Anstey KJ
Psychol Aging; 2014 Jun; 29(2):393-403. PubMed ID: 24956006
[TBL] [Abstract][Full Text] [Related]
16. The genetic influence of the brain-derived neurotrophic factor Val66Met polymorphism in chronic low back pain.
Yamada AS; Antunes FTT; Ferraz C; de Souza AH; Simon D
Adv Rheumatol; 2021 May; 61(1):24. PubMed ID: 33980293
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis.
Tammimäki A; Männistö PT
Pharmacogenet Genomics; 2012 Sep; 22(9):673-91. PubMed ID: 22722321
[TBL] [Abstract][Full Text] [Related]
18. Pulp Sensitivity: Influence of Sex, Psychosocial Variables, COMT Gene, and Chronic Facial Pain.
Mladenovic I; Krunic J; Supic G; Kozomara R; Bokonjic D; Stojanovic N; Magic Z
J Endod; 2018 May; 44(5):717-721.e1. PubMed ID: 29550002
[TBL] [Abstract][Full Text] [Related]
19. Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Flor A; Morales D; Peiró AM
Clin J Pain; 2020 Jun; 36(6):420-429. PubMed ID: 32149782
[TBL] [Abstract][Full Text] [Related]
20. Associations of catechol-O-methyltransferase (rs4680) single nucleotide polymorphisms with opioid use and dose among adults with chronic pain.
Hooten WM; Biernacka JM; O'Brien TG; Cunningham JM; Black JL
Pain; 2019 Jan; 160(1):263-268. PubMed ID: 30211780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
